AFIB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AFIB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Interest Income only applies to banks.
Takeo Mukai | officer: Interim CFO | C/O ACUTUS MEDICAL, INC., 2210 FARADAY AVE., SUITE 100, CARLSBAD CA 92008 |
Jason K Garland | director | 10000 WEHRLE DRIVE, CLARENCE NY 14031 |
Kevin Mathews | officer: SVP, Global Sales | C/O ACUTUS MEDICAL, INC., 2210 FARADAY AVE., SUITE 100, CARLSBAD CA 92008 |
Charlie Piscitello | officer: Chief People Officer | 2210 FARADAY AVE #100, CARLSBAD CA 92008 |
Tom Sohn | officer: SVP, Gen. Counsel & Secretary | 2210 FARADAY AVE #100, CARLSBAD CA 92008 |
R Scott Huennekens | director | C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130 |
James F. Hinrichs | director | 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Niamh Louise Pellegrini | director | C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065 |
Orbimed Rof Ii Llc | director, 10 percent owner | 601 LEXINGTON AVE., 54TH FLOOR, NEW YORK NY 10022 |
David P Bonita | director, 10 percent owner | C/O ORBIMED ADVISORS LLC, 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Orbimed Advisors Llc | director, 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
James E Flynn | director, 10 percent owner, other: Director by Deputization | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Orbimed Capital Gp Iv Llc | director, 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
John F Sheridan | director | C/O TANDEM DIABETES CARE, INC., 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
David Roman | officer: SVP & Chief Financial Officer | ACUTUS MEDICAL, INC., 2210 FARADAY AVE, SUITE 100, CARLSBAD CA 92008 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.